ArticleDiabetes, obesity & metabolism2025

Evaluation of efficacy of iGlarLixi versus IDegAsp using derived time-in-ranges in Chinese adults with Type 2 diabetes: A post hoc analysis of the Soli-D study.

Juan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.